Metagenomi Therapeutics ROE 2022-2026 | MGX
Current and historical return on equity (ROE) values for Metagenomi Therapeutics (MGX) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
| Metagenomi Therapeutics ROE - Return on Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Shareholder's Equity | Return on Equity |
| 2026-03-31 | $-0.09B | $0.17B | -51.27% |
| 2025-12-31 | $-0.09B | $0.19B | -47.18% |
| 2025-09-30 | $-0.09B | $0.21B | -42.82% |
| 2025-06-30 | $-0.09B | $0.23B | -38.67% |
| 2025-03-31 | $-0.08B | $0.24B | -32.07% |
| 2024-12-31 | $-0.08B | $0.26B | -30.12% |
| 2024-09-30 | $-0.07B | $0.25B | -29.13% |
| 2024-06-30 | $-0.08B | $0.19B | -39.47% |
| 2024-03-31 | $-0.08B | $0.12B | -62.73% |
| 2023-12-31 | $-0.07B | $0.05B | -126.51% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Generic Drugs | $0.052B | $0.025B |
| Metagenomi Therapeutics Inc. is an in vivo genome editing company capitalizing on its proprietary technologies to create curative genetic medicines for patients. Metagenomi Therapeutics Inc., formerly known as Metagenomi Inc., is based in EMERYVILLE, Calif. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Teva Pharmaceutical Industries (TEVA) | Israel | $35.437B | 10.97 |
| BridgeBio Pharma (BBIO) | United States | $14.460B | 0.00 |
| Dr Reddy's Laboratories (RDY) | India | $11.109B | 17.29 |
| Aspen Pharmacare (APNHY) | South Africa | $3.708B | 0.00 |
| Supernus Pharmaceuticals (SUPN) | United States | $2.918B | 22.33 |
| Bausch Health Cos (BHC) | Canada | $2.086B | 1.50 |
| Taysha Gene Therapies (TSHA) | United States | $1.290B | 0.00 |
| Amphastar Pharmaceuticals (AMPH) | United States | $0.924B | 7.28 |
| Personalis (PSNL) | United States | $0.630B | 0.00 |
| Assembly Biosciences (ASMB) | United States | $0.451B | 0.00 |
| Sol-Gel Technologies (SLGL) | Israel | $0.210B | 0.00 |
| Evoke Pharma (EVOK) | United States | $0.019B | 0.00 |
| Teligent (TLGT) | United States | $0.000B | 0.00 |